Study guide

2.2 Dosage Forms, Routes, and Administration Instructions

PTCB Medication Therapy Management Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts & Format 1.2 Eligibility, Application & Testing 1.3 Pharmacy Technician Role in MTM 1.4 Domain Weights & Study Strategy

2 Chapter 2: Medication Product Knowledge

2.1 Strengths, Doses, and Drug Classes 2.2 Dosage Forms, Routes, and Administration Instructions 2.3 Storage, Special Handling, and Duration of Therapy 2.4 Interchangeable Classes and Forms for Cost Savings

3 Chapter 3: Terminology & History Collection

3.1 Patient-Friendly Medical Terminology 3.2 Medication Allergy vs Medication Intolerance 3.3 Adherence Definitions in Medication History 3.4 Medical History Components for MTM

4 Chapter 4: Medication-Related Problems & Labs

4.1 Common Medication-Related Problems Overview 4.2 Side Effects, Adverse Drug Reactions & Allergies in MTM 4.3 Nonadherence, Affordability Barriers & Gaps in Therapy 4.4 Lab Measures & Related Medical Terms in MTM

5 Chapter 5: Adherence Calculations

5.1 Days’ Supply, Quantity, and Dose 5.2 Proportion of Days Covered (PDC) 5.3 PQA Threshold & Star Ratings Adherence Measures

6 Chapter 6: Documentation Accuracy Reviews

6.1 Personal Medication Record (PMR) Accuracy Review 6.2 MAP and CMR Documentation Accuracy 6.3 MTM Billing Fields Accuracy Checks

7 Chapter 7: Prescribing Errors & Therapy Conflicts

7.1 Types of Prescribing Errors 7.2 Inappropriate Prescribing & Duplicate Therapy 7.3 Drug Interactions & Conflicting Therapies 7.4 Impact of Prescribing Errors & Medication Problems

8 Chapter 8: High-Risk Medications in Older Adults

8.1 2023 AGS Beers Criteria: High-Risk Medications in Older Adults 8.2 STOPP/START Concepts & Anticholinergic Burden in MTM Screening 8.3 High-Alert & Narrow Therapeutic Index Awareness for MTM Tech Support

9 Chapter 9: MTM Core Elements

9.1 Purpose of MTM & Five Core Elements 9.2 Medication Therapy Review (MTR) 9.3 Personal Medication Record (PMR) 9.4 Medication-Related Action Plan (MAP)

10 Chapter 10: Intervention, Documentation & CMS Rules

10.1 Intervention, Referral & Follow-Up 10.2 MTM Documentation Standards 10.3 CMS Part D MTM Targeting Requirements

11 Chapter 11: CMR, TMR, Billing & Workflow

11.1 Comprehensive Medication Review (CMR) 11.2 Targeted Medication Review (TMR) 11.3 CPT Billing Codes for MTM (99605 / 99606 / 99607) 11.4 Workflow Prioritization, Stages & Timelines

2.2 Dosage Forms, Routes, and Administration Instructions

Key Takeaways Explain This Topic AI

Dosage form (tablet, capsule, patch, inhaler, suspension) and route (oral, topical, inhaled, injectable) must match both the prescription intent and how the patient actually uses the product.

Special administration instructions—crushing restrictions, food requirements, device priming, patch site rotation—are high-yield MTM verification items.

Incorrect route or form (swallowing a buccal tablet, cutting a long-acting patch) can create serious MRPs; flag for pharmacist counseling.

Technicians help patients describe devices and techniques in plain language, then escalate technique problems that affect efficacy or safety.

Never assume two products with the same drug name are interchangeable across forms without pharmacist review (for example, IR tablet vs. ER capsule vs. patch).

Last updated: August 2026

2.2 Dosage Forms, Routes, and Administration Instructions

Quick Answer: MTM technicians confirm each drug’s dosage form , route , and special administration instructions , then compare those facts to patient-reported use. Wrong form or route (crushing an ER tablet, swallowing a sublingual product whole) is a medication-related problem to flag—not something the technician “fixes” by changing therapy alone.

Strength and class tell you what drug and how much . Form and route tell you how the drug is delivered . Domain 1 explicitly includes dosage forms, routes of administration, and special administration instructions because many adherence and safety problems hide in technique, not in the fill history.

Core Dosage Forms Technicians Must Recognize

Dosage form Typical route MTM verification focus

Immediate-release tablet/capsule Oral (PO) Can it be split/crushed? Taken with food?

Extended-release / delayed-release (ER, XR, XL, SR, DR, EC) Oral Usually do not crush/chew; timing may differ from IR

Oral disintegrating tablet (ODT) Oral transmucosal / oral Dissolves on tongue; not the same as a standard swallow tablet

  • Sublingual / buccal tablet Under tongue / cheek Must not be swallowed whole for intended effect
  • Oral liquid / suspension Oral Shake if required; use correct measuring device
  • Transdermal patch Topical → systemic Site rotation, wear time, heat exposure, disposal
  • Topical cream/ointment/gel Skin (local) Thin layer vs. occlusion; area of application
  • Eye/ear drops Ophthalmic / otic Which eye/ear; contact lens rules; contamination
  • Inhalers / nebulizer solutions Inhalation Device type, priming, spacer, rinse after steroid
  • Injectables (pen, vial, syringe) Subcutaneous / IM / IV Injection site, angle, refrigeration, needle safety
  • Suppository Rectal / vaginal Storage (some need refrigeration); insertion technique

When building a PMR, record the form the patient actually uses. “Metoprolol” is incomplete if the patient uses metoprolol succinate ER tablets vs. metoprolol tartrate IR tablets —dose conversion and frequency differ and require pharmacist oversight.

Routes of Administration: Matching Intent to Use

Route abbreviations appear on labels and profiles; technicians should translate them into patient-friendly language during history interviews.

  • Abbreviation / term Meaning Interview prompt example
  • PO By mouth “Do you swallow this with water?”
  • SL Under the tongue “Do you let it dissolve under your tongue?”
  • PR Rectally Confirm storage and insertion instructions
  • TOP On the skin Confirm area and whether covered
  • INH Inhaled Ask which device and how often used
  • SC / SQ Under the skin Ask where they inject and rotation pattern
  • IM Into muscle Usually clinic-administered; confirm setting
  • IV Into vein Typically facility-administered
  • OU / OS / OD Both / left / right eye Critical for ophthalmic products
  • MTM technician scenario: wrong route use

A patient lists nitroglycerin “pills for chest pain.” The technician asks how they take it. The patient says they “swallow it with water when my chest hurts.” The product is nitroglycerin sublingual . Swallowing may delay or reduce the intended effect. The technician documents the technique problem and flags the pharmacist for urgent counseling—without redesigning anti-anginal therapy independently.

Special Administration Instructions That Drive MTM Flags

Special instructions are label or counseling points that change efficacy or safety if ignored. High-yield categories:

1. Do not crush / chew / split

Extended-release and enteric-coated products are common crush-risk items. Crushing can dump the full dose at once (dose dumping) or destroy acid protection. If a patient reports crushing pills for a feeding tube or “because they’re too big,” identify the form and escalate. Alternative forms (liquid, crushable IR, patch) are pharmacist/prescriber decisions.

2. Food and timing requirements

  • Instruction type Examples Why it matters in MTM
  • Take with food Metformin (GI tolerance), some NSAIDs Affects adherence and side effects
  • Take on empty stomach Levothyroxine (commonly), bisphosphonates Timing errors reduce absorption

Separate from other meds/supplements Levothyroxine vs. calcium/iron; binding interactions Looks like “nonadherence” to labs if timing is wrong

  • Same time daily Many antihypertensives, antiretrovirals Supports PDC conversations later
  • 3. Device and technique instructions

Inhalers: Prime new devices; breathe out fully; seal lips; inhale slowly or forcefully depending on MDI vs. DPI; hold breath; rinse mouth after inhaled corticosteroids.

Insulin pens: Attach new needle, prime, dial correct units, inject into recommended sites, hold count, dispose of sharps safely.

Patches: Apply to clean dry skin, rotate sites, press firmly, avoid heating pads, fold and dispose securely after removal.

Technique problems are adherence-related MRPs even when fills look perfect (PDC may be high while inhaler use is incorrect).

4. Combination and multi-step regimens

Some products require sequencing (for example, using a short-acting bronchodilator before a corticosteroid inhaler when directed). Others require reconstitution of oral suspensions with specific shake-and-measure steps. Confirm that caregivers know measuring devices are not interchangeable with household teaspoons.

Form Switches Are Not Automatic

Patients and plans often ask whether a tablet can become a capsule, liquid, or patch for convenience or cost. From a product-knowledge standpoint:

Same active ingredient does not always mean same release profile or bioavailability.

Topical and systemic forms are not interchangeable for the same indication without clinical review.

“Take half a patch” or “cut the ER tablet” may be unsafe.

The technician’s job is to identify the opportunity or risk and route it to the pharmacist. Cost-saving form switches are covered in depth in Section 2.4; here, remember that form and route accuracy comes first.

Documentation Tips for Forms and Routes on the PMR

For each medication entry, aim for clarity a caregiver or covering clinician can follow:

Drug name + strength + form (for example, “pantoprazole 40 mg delayed-release tablet”).

Route in plain language (“by mouth,” “on the skin,” “inhaled”).

Special instructions the patient must follow (“do not crush,” “dissolve under the tongue,” “inject in the abdomen”).

Patient-reported technique issues noted separately as flags for the pharmacist’s MAP.

Scenario: patch wear-time error

A patient’s profile shows a fentanyl patch every 72 hours. The patient says they change it “every night because the pain comes back.” The technician recognizes a duration/administration mismatch, documents the reported wear interval, and escalates immediately. Shortened wear time can indicate uncontrolled pain, misuse risk, or misunderstanding—all pharmacist-managed clinical issues.

Quick Self-Check for Exam and Practice

Ask yourself for every medication on a practice list:

What form is it?

What route should it use?

What special instruction would make this product fail if ignored?

Did the patient describe use that matches the label?

If not, did I flag the pharmacist with a clear note?

Technicians who master forms, routes, and administration instructions catch problems that pure refill data never show—and that is exactly the product-knowledge skill PTCB MTM Domain 1 targets.